MicroRNA-92a Promotes Lymph Node Metastasis of Human Esophageal Squamous Cell Carcinoma Via E-cadherin
Overview
Authors
Affiliations
microRNAs (miRNAs) regulate gene expression at the post-transcriptional level and play important roles in tumor initiation and progression. Recently, we examined the global miRNA expression profile of esophageal squamous cell carcinoma (ESCC) and demonstrated that miR-92a was highly expressed in tumor tissues. In this study, we found that the up-regulation of miR-92a was significantly correlated with the status of lymph node metastasis and TNM stage in 107 ESCC patients. Moreover, the up-regulation of miR-92a was associated with poor survival of ESCC patients and might be used as an independent prognostic factor. Next, we investigated the role and mechanism of miR-92a in ESCC cells, and found that miR-92a modulated the migration and invasion but not apoptosis and proliferation of ESCC cells in vitro. We further demonstrated that miR-92a directly targeted the CDH1 3'-UTR and repressed the expression of CDH1, a tumor metastasis suppressor. In addition, restoring of miR-92a-resistant CDH1 expression in miR-92a-overexpression cells recovered the pro-metastasis activity of miR-92a. Taken together, we demonstrated that miR-92a promotes ESCC cell migration and invasion at least partially via suppression of CDH1 expression, and patients with up-regulated miR-92a are prone to lymph node metastasis and thus have poor prognosis.
Zhang Y, Wan Y, Li J, Ju S, Tong X, Wu J Front Immunol. 2025; 16:1556509.
PMID: 40070828 PMC: 11894379. DOI: 10.3389/fimmu.2025.1556509.
Williams M, Howard D, Donnelly C, Izadi F, Parra J, Pugh M Cell Commun Signal. 2024; 22(1):443.
PMID: 39285292 PMC: 11404028. DOI: 10.1186/s12964-024-01806-4.
Escalante P, Quinones L, Contreras H Front Pharmacol. 2024; 15:1376638.
PMID: 38659583 PMC: 11039864. DOI: 10.3389/fphar.2024.1376638.
MicroRNAs: A novel signature in the metastasis of esophageal squamous cell carcinoma.
Wei Q, Jin F, Wang Z, Li B, Cao W, Sun Z World J Gastroenterol. 2024; 30(11):1497-1523.
PMID: 38617454 PMC: 11008420. DOI: 10.3748/wjg.v30.i11.1497.
Saikia S, Postwala H, Athilingam V, Anandan A, Padma V, Kalita P Curr Pharm Biotechnol. 2024; 25(15):1915-1938.
PMID: 38310451 DOI: 10.2174/0113892010265004231116092802.